BDNF val66met genotype and schizotypal personality traits interact to influence probabilistic association learning

Behavioural Brain Research

Volumn 274, Issue , 2014, Pages 137-142

  Skilleter, Ashley Jayne ^a,b,c   Weickert, Cynthia Shannon ^a,b,c   Moustafa, Ahmed Abdelhalim ^d   Gendy, Rasha ^e   Chan, Mico ^e   Arifin, Nur ^e   Mitchell, Philip Bowden ^a,f   Weickert, Thomas Wesley ^a,b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^d WESTERN SYDNEY UNIVERSITY   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f BLACK DOG INSTITUTE   (Australia)

Author keywords

Brain derived neurotrophic factor val66met polymorphism; Probabilistic association learning; Schizotypal personality

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; FEMALE; GENETIC POLYMORPHISM; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; QUESTIONNAIRE; SCHIZOTYPAL PERSONALITY DISORDER; ANALYSIS OF VARIANCE; COMPLICATION; GENETICS; GENOTYPE; LEARNING DISORDERS; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ANALYSIS OF VARIANCE; ASSOCIATION LEARNING; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GENOTYPE; HUMANS; LEARNING DISORDERS; MALE; METHIONINE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROBABILITY LEARNING; PSYCHIATRIC STATUS RATING SCALES; SCHIZOTYPAL PERSONALITY DISORDER; VALINE; YOUNG ADULT;

EID: 84906502964     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.07.041     Document Type: Article

References (53)

1. Bekinschtein P., Cammarota M., Katche C., Slipczuk L., Rossato J.I., Goldin A., et al. BDNF is essential to promote persistence of long-term memory storage. Proc Natl Acad Sci U S A 2008, 105(7):2711-2716.
2. Durany N., Thome J. Neurotrophic factors and the pathophysiology of schizophrenic psychoses. Eur Psychiatry 2004, 19(6):326-337.
3. Lu B. BDNF and activity-dependent synaptic modulation. Learn Mem 2003, 10(2):86-98.
4. Lu B., Chow A. Neurotrophins and hippocampal synaptic transmission and plasticity. J Neurosci Res 1999, 58(1):76-87.
5. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112(2):257-269.
6. Dempster E., Toulopoulou T., McDonald C., Bramon E., Walshe M., Filbey F., et al. Association between BDNF val66 met genotype and episodic memory. Am J Med Genet B Neuropsychiatr Genet 2005, 134B(1):73-75.
7. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003, 23(17):6690-6694.
8. Neves-Pereira M., Cheung J.K., Pasdar A., Zhang F., Breen G., Yates P., et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 2005, 10(2):208-212.
9. Rosa A., Cuesta M.J., Fatjo-Vilas M., Peralta V., Zarzuela A., Fananas L. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study. Am J Med Genet B Neuropsychiatr Genet 2006, 141B(2):135-138.
10. Weickert T.W., Goldberg T.E., Gold J.M., Bigelow L.B., Egan M.F., Weinberger D.R. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry 2000, 57(9):907-913.
11. Fera F., Weickert T.W., Goldberg T.E., Tessitore A., Hariri A., Das S., et al. Neural mechanisms underlying probabilistic category learning in normal aging. J Neurosci 2005, 25(49):11340-11348.
12. Poldrack R.A., Clark J., Pare-Blagoev E.J., Shohamy D., Creso Moyano J., Myers C., et al. Interactive memory systems in the human brain. Nature 2001, 414(6863):546-550.
13. Poldrack R.A., Prabhakaran V., Seger C.A., Gabrieli J.D. Striatal activation during acquisition of a cognitive skill. Neuropsychology 1999, 13(4):564-574.
14. Skilleter A.J., Weickert C.S., Vercammen A., Lenroot R., Weickert T.W. Peripheral BDNF. A candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia. Psychol Med 2014, (in press).
15. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004, 24(45):10099-10102.
16. Rybakowski J.K., Borkowska A., Czerski P.M., Skibinska M., Hauser J. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 2003, 5(6):468-472.
17. Rybakowski J.K., Borkowska A., Skibinska M., Szczepankiewicz A., Kapelski P., Leszczynska-Rodziewicz A., et al. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin Neurosci 2006, 60(1):70-76.
18. Whalley H.C., Baig B.J., Hall J., Job D.E., McIntosh A.M., Cunningham-Owens D.G., et al. Effects of the BDNF val66met polymorphism on prefrontal brain function in a population at high genetic risk of schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2010, 153B(8):1474-1482.
19. Foerde K., Poldrack R.A., Khan B.J., Sabb F.W., Bookheimer S.Y., Bilder R.M., et al. Selective corticostriatal dysfunction in schizophrenia: examination of motor and cognitive skill learning. Neuropsychology 2008, 22(1):100-109.
20. Horan W.P., Green M.F., Knowlton B.J., Wynn J.K., Mintz J., Nuechterlein K.H. Impaired implicit learning in schizophrenia. Neuropsychology 2008, 22(5):606-617.
21. Weickert T.W., Goldberg T.E., Egan M.F., Apud J.A., Meeter M., Myers C.E., et al. Relative risk of probabilistic category learning deficits in patients with schizophrenia and their siblings. Biol Psychiatry 2010, 67(10):948-955.
22. Weickert T.W., Terrazas A., Bigelow L.B., Malley J.D., Hyde T., Egan M.F., et al. Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input. Learn Mem 2002, 9(6):430-442.
23. Weickert T.W., Goldberg T.E., Callicott J.H., Chen Q., Apud J.A., Das S., et al. Neural correlates of probabilistic category learning in patients with schizophrenia. J Neurosci 2009, 29(4):1244-1254.
24. Boyle G.J. Schizotypal personality traits: an extension of previous psychometric investigations. Aust J Psychol 1998, 50:114-118.
25. Vollema M.G., van den Bosch R.J. The multidimensionality of schizotypy. Schizophr Bull 1995, 21(1):19-31.
26. Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington, DC. 4th ed.
27. Miller P., Byrne M., Hodges A., Lawrie S.M., Owens D.G., Johnstone E.C. Schizotypal components in people at high risk of developing schizophrenia: early findings from the Edinburgh High-Risk Study. Br J Psychiatry 2002, 180:179-184.
28. Stefanis N.C., Trikalinos T.A., Avramopoulos D., Smyrnis N., Evdokimidis I., Ntzani E.E., et al. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol Psychiatry 2007, 62(7):784-792.
29. Simons C.J., Wichers M., Derom C., Thiery E., Myin-Germeys I., Krabbendam L., et al. Subtle gene-environment interactions driving paranoia in daily life. Genes Brain Behav 2009, 8(1):5-12.
30. Kendler K.S., McGuire M., Gruenberg A.M., O'Hare A., Spellman M., Walsh D. The Roscommon Family Study. III. Schizophrenia-related personality disorders in relatives. Arch Gen Psychiatry 1993, 50(10):781-788.
31. Kotsaftis A., Neale J.M. Schizotypal personality disorder: 1. The clinical syndrome. Clin Psychol Rev 1993, 13:451-472.
32. Lenzenweger M.F., Loranger A.W. Detection of familial schizophrenia using a psychometric measure of schizotypy. Arch Gen Psychiatry 1989, 46(10):902-907.
33. Tsuang M.T., Stone W.S., Faraone S.V. Schizophrenia: a review of genetic studies. Harv Rev Psychiatry 1999, 7(4):185-207.
34. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997, 389(6653):856-860.
35. Wechsler D. Wechsler Adult Intelligence Scale 1997, The Psychological Corporation, San Antonio, TX.
36. Lovibond S.H., Lovibond P.F. Manual for depression anxiety stress scales 1995, Psychology Foundation Monograph, Sydney.
37. Ware J.E., Kosinski M., Gandek B. SF36 health survey: manual and interpretation guide 2005, Quality Metric, Lincoln.
38. Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull 1991, 17(4):555-564.
39. Raine A., Reynolds C., Lencz T., Scerbo A., Triphon N., Kim D. Cognitive-perceptual, interpersonal, and disorganized features of schizotypal personality. Schizophr Bull 1994, 20(1):191-201.
40. Knowlton B.J., Mangels J.A., Squire L.R. A neostriatal habit learning system in humans. Science 1996, 273(5280):1399-1402.
41. Gluck M.A., Shohamy D., Myers C. How do people solve the weather prediction" task?: individual variability in strategies for probabilistic category learning. Learn Mem 2002, 9(6):408-418.
42. Meeter M., Myers C.E., Shohamy D., Hopkins R.O., Gluck M.A. Strategies in probabilistic categorization: results from a new way of analyzing performance. Learn Mem 2006, 13(2):230-239.
43. Murray G.K., Corlett P.R., Clark L., Pessiglione M., Blackwell A.D., Honey G., et al. Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry 2008, 13(3):239. 67-76.
44. Howes O.D., Montgomery A.J., Asselin M.C., Murray R.M., Valli I., Tabraham P., et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 2009, 66(1):13-20.
45. Fusar-Poli P., Howes O.D., Allen P., Broome M., Valli I., Asselin M.C., et al. Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Mol Psychiatry 2011, 16(1):67-75.
46. Wagshal D., Knowlton B.J., Cohen J.R., Poldrack R.A., Bookheimer S.Y., Bilder R.M., et al. Impaired automatization of a cognitive skill in first-degree relatives of patients with schizophrenia. Psychiatry Res 2014, 215:294-299.
47. Noguchi H., Hori H., Kunugi H. Schizotypal traits and cognitive function in healthy adults. Psychiatry Res 2008, 161(2):162-169.
48. McClure M.M., Harvey P.D., Bowie C.R., Iacoviello B., Siever L.J. Functional outcomes, functional capacity, and cognitive impairment in schizotypal personality disorder. Schizophr Res 2013, 144(1-3):146-150.
49. Eisenberg D.P., Ianni A.M., Wei S.M., Kohn P.D., Kolachana B., Apud J., et al. Brain-derived neurotrophic factor (BDNF) Val(66)Met polymorphism differentially predicts hippocampal function in medication-free patients with schizophrenia. Mol Psychiatry 2013, 18(6):713-720.
50. Tsai S.J., Hong C.J., Yu Y.W., Chen T.J. Association study of a brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and personality trait and intelligence in healthy young females. Neuropsychobiology 2004, 49(1):13-16.
51. Moustafa A.A., Gluck M.A. A neurocomputational model of dopamine and prefrontal-striatal interactions during multicue category learning by Parkinson patients. J Cogn Neurosci 2011, 23(1):151-167.
52. Barkus E., Lewis S. Schizotypy and psychosis like experiences from recreational cannabis in a non-clinical sample. Psychol Med 2008, 38(9):1267-1276.
53. Pivac N., Kim B., Nedic G., Joo Y.H., Kozaric-Kovacic D., Hong J.P., et al. Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants. Croat Med J 2009, 50(1):43-48.